相关实验视频
Updated: May 15, 2026

09:52
An Implantable System For Chronic In Vivo Electromyography
Published on: April 21, 2020
10.6K
低光神经刺激呼吸道迁移:MAUDE数据库审查和案例报告
Emily A Commesso1, Marcus F Paoletti2, Eric J Kezirian3
1Department of Head and Neck Surgery & Communication Sciences Duke University School of Medicine Durham North Carolina USA.
OTO open
|June 13, 2025
概括
呼吸道感应迁移是阻塞性睡眠呼吸暂停的低分泌神经刺激 (HGNS) 的罕见并发症. 这项研究分析了MAUDE数据库事件,发现151例呼吸道并发症中的75例发生了迁移,其中罕见的肺胸病例.
科学领域:
- 医疗器械 医疗器械
- 睡眠医学 睡眠医学
- 手术并发症 手术并发症
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是通过单边的下神经刺激 (HGNS) 来治疗的.
- HGNS涉及脉冲发生器,呼吸道感应和刺激,并可能导致并发症.
- 之前的研究报告了HGNS的整体不良事件发生率.
研究的目的:
- 用FDA的MAUDE数据库提供关于HGNS并发症的最新报告.
- 专注于与呼吸道感应相关的并发症,特别是迁移.
- 提出一个护理算法,并讨论感知迁移的两个案例.
主要方法:
- 追溯横截面研究和案例报告.
- 在MAUDE数据库中查询HGNS呼吸传感事件 (2000-2022年).
- 主要结局:呼吸道迁移导致肺胸或需要修订/移植.
主要成果:
- 765个HGNS不良事件中的151个涉及呼吸道感应;75个是迁移.
- 七个事件涉及感知向腔空间的迁移,其中六个需要修复手术 (<1%的HGNS不良事件).
- 由于感知迁移而引起的肺胸病例有两例;详细介绍了两个机构特定的病例.
结论:
- 呼吸道感应迁移是HGNS对OSA的一个罕见并发症.
- 多学科的外科规划对于管理潜在的迁移感应是必不可少的.
- 根据迁移的程度和复杂性,可能需要考虑进行手术前或手术后的胸管安置.
相关概念视频
Respiratory System Abnormal Finding II: Palpation and Auscultation
In assessing respiratory abnormalities, palpation and auscultation are critical tools for detecting and interpreting various pathophysiological changes. These techniques provide insight into underlying disorders by evaluating tactile sensations and sounds produced by the respiratory system.
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

